JADE101 is an investigational, potentially best-in-class disease-modifying anti-APRIL monoclonal antibody, with a Phase 1 healthy volunteer study underway JADE101 is designed to selectively inhibit A ...
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results